We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEGG
13376
Sports Entertainment Gaming Global Corp
SEGG
$8.21M
$14.2K ﹤0.01%
+419
New +$11.8K
TRMK icon
13377
PUT
Trustmark
TRMK
$2.8B
$14.1K ﹤0.01%
400
+300
+300% +$10.8K
GILT icon
13378
CALL
Gilat Satellite Networks
GILT
$887M
$14.1K ﹤0.01%
2,300
+1,700
+283% +$9.26K
TBBB icon
13379
PUT
BBB Foods
TBBB
$5.76B
$14.1K ﹤0.01%
500
-800
-62% -$24.9K
INZY
13380
PUT
DELISTED
Inozyme Pharma
INZY
$14.1K ﹤0.01%
5,100
-700
-12% -$2.66K
CPSS icon
13381
CALL
Consumer Portfolio Services
CPSS
$205M
$14.1K ﹤0.01%
+1,300
New +$13.3K
CGDV icon
13382
PUT
Capital Group Dividend Value ETF
CGDV
$38.8B
$14.1K ﹤0.01%
+400
New +$14.6K
KW
13383
CALL
DELISTED
Kennedy-Wilson Holdings
KW
$14K ﹤0.01%
1,400
-17,100
-92% -$187K
UONEK icon
13384
Urban One Class D
UONEK
$23.4M
$14K ﹤0.01%
1,402
-731
-34% -$7.61K
PANL icon
13385
PUT
Pangaea Logistics
PANL
$487M
$13.9K ﹤0.01%
2,600
-1,600
-38% -$9.64K
SPFI icon
13386
PUT
South Plains Financial
SPFI
$858M
$13.9K ﹤0.01%
400
+300
+300% +$10.9K
INVA icon
13387
PUT
Innoviva
INVA
$1.53B
$13.9K ﹤0.01%
800
+500
+167% +$9.6K
MRSN
13388
PUT
DELISTED
Mersana Therapeutics
MRSN
$13.9K ﹤0.01%
388
-700
-64% -$36.2K
EMLC icon
13389
PUT
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$13.9K ﹤0.01%
+600
New +$14.4K
THFF icon
13390
PUT
First Financial Corp
THFF
$976M
$13.9K ﹤0.01%
300
-200
-40% -$9.27K
CNXN icon
13391
CALL
PC Connection
CNXN
$2.05B
$13.9K ﹤0.01%
200
-900
-82% -$64.7K
BRFS
13392
CALL
DELISTED
BRF SA
BRFS
$13.8K ﹤0.01%
3,400
-173,700
-98% -$754K
ENLV icon
13393
CALL
Enlivex Ltd
ENLV
$26.6M
$13.8K ﹤0.01%
787
-600
-43% -$11.7K
ORGO icon
13394
CALL
Organogenesis Holdings
ORGO
$230M
$13.8K ﹤0.01%
+4,300
New +$14.4K
VICI icon
13395
VICI Properties
VICI
$29B
$13.8K ﹤0.01%
471
-3,700,203
-100% -$117M
NNBR icon
13396
CALL
NN Inc
NNBR
$322M
$13.7K ﹤0.01%
4,200
+3,300
+367% +$12.6K
RZLT icon
13397
PUT
Rezolute
RZLT
$443M
$13.7K ﹤0.01%
2,800
-21,800
-89% -$110K
TNGX icon
13398
PUT
Tango Therapeutics
TNGX
$4.32B
$13.6K ﹤0.01%
4,400
+2,900
+193% +$13.5K
IRS
13399
PUT
IRSA Inversiones y Representaciones
IRS
$1.24B
$13.6K ﹤0.01%
909
-1,370
-60% -$19.4K
AIA icon
13400
PUT
iShares Asia 50 ETF
AIA
$5.06B
$13.6K ﹤0.01%
200

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.